Fox Chase Cancer Center News

PHILADELPHIA (February 27, 2020) – Eileen K. Jaffe, PhD, a professor in the Molecular Therapeutics program at Fox Chase Cancer Center, was recently tapped to help write the book "Oligomerization in Health and Disease: From Enzymes to G Protein-Couple Receptors."

PHILADELPHIA (February 25, 2020) – Vladimir Kolenko, MD, PhD, received the two-year $200,000 NCI grant to target cholesterol homeostasis using genetic and pharmacological approaches in order to reinstate or re-emphasize sensitivity of prostate cancer cells to anti-androgens like abiraterone and enzalutamide.

PHILADELPHIA (February 20, 2020) – Neal S. Topham, MD, FACS, researched the use of a new resorbable mesh to minimize the risk of hernias and bulges after bilateral flap breast reconstruction.

PHILADELPHIA (February 19, 2020) – Edna Cukierman and Igor Astsaturov were among a group of almost 30 experts convened to discuss the current understanding of CAFs.

PHILADELPHIA (February 18, 2020) – In a study published today, researchers at Fox Chase Cancer Center have identified a new kinase target for the treatment of high-grade serous ovarian cancer that has the potential to lead to the development of new drugs.

PHILADELPHIA (February 14, 2020) – Dr. Cukierman's induction as a fellow is notable because historically AGA has been a medical association. Cukierman is not a medical doctor, but she joined AGA in order to better understand the medical side of gastroenterology.

PHILADELPHIA (February 13, 2020) – A research article featuring featured Fox Chase Cancer Center  was awarded the 2019 Journal of Oncology Practice (JOP) Editor’s Pick Award for being one of the top five most-read articles published in JOP in 2019.

PHILADELPHIA (February 10, 2020)—Its involvement in causing over 50 percent of all cancers makes p53 one of the most well-known cancer genes. But there are some malignancies, like kidney cancer, that rarely have p53 mutations.